Buprenorphine HCl and Naloxone HCl (AvKARE, Inc.)
Welcome to the PulseAid listing for the Buprenorphine HCl and Naloxone HCl drug offered from AvKARE, Inc.. This Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | AvKARE, Inc. |
NON-PROPRIETARY NAME: | Buprenorphine and Naloxone |
SUBSTANCE NAME: | BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Partial Opioid Agonist [EPC],Partial Opioid Agonists [MoA],Opioid Antagonist [EPC],Opioid Antagonists [MoA] |
ROUTE: | SUBLINGUAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2013-04-01 |
END MARKETING DATE: | 0000-00-00 |
Buprenorphine HCl and Naloxone HCl HUMAN PRESCRIPTION DRUG Details:
Item Description | Buprenorphine HCl and Naloxone HCl from AvKARE, Inc. |
LABELER NAME: | AvKARE, Inc. |
DEA SCHEDULE: | CIII
|
ACTIVE STRENGTH: | 2; .5(mg/1; mg/1) |
START MARKETING DATE: | 2013-04-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 42291-174_14457631-c51c-27ef-9fc9-6a8fa33356d3 |
PRODUCT NDC: | 42291-174 |
APPLICATION NUMBER: | ANDA203136 |
Other BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE DIHYDRATE Pharmaceutical Manufacturers / Labelers: